Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Cash from Investing Activities (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Cash from Investing Activities for 16 consecutive years, with $198000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 115.15% to $198000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$401000.0, a 95.19% increase, with the full-year FY2025 number at -$401000.0, up 95.19% from a year prior.
  • Cash from Investing Activities was $198000.0 for Q4 2025 at Anika Therapeutics, up from -$1.7 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q1 2021 to a low of -$3.4 million in Q2 2024.
  • A 5-year average of -$1.2 million and a median of -$1.4 million in 2023 define the central range for Cash from Investing Activities.
  • Peak YoY movement for Cash from Investing Activities: plummeted 176.47% in 2022, then soared 192.48% in 2025.
  • Anika Therapeutics' Cash from Investing Activities stood at -$1.2 million in 2021, then crashed by 103.95% to -$2.5 million in 2022, then rose by 27.24% to -$1.8 million in 2023, then increased by 28.97% to -$1.3 million in 2024, then surged by 115.15% to $198000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Cash from Investing Activities are $198000.0 (Q4 2025), -$1.7 million (Q3 2025), and -$539000.0 (Q2 2025).